Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)

1.	Calder, P C: 7 articles (04/2005 - 01/2001)
2.	Calder, Philip C: 6 articles (08/2008 - 01/2003)
3.	Das, Undurti N: 6 articles (01/2008 - 04/2002)
4.	Leaf, Alexander: 6 articles (09/2007 - 01/2002)
5.	Das, U N: 6 articles (02/2004 - 02/2001)
6.	Schmidt, Erik Berg: 4 articles (06/2008 - 01/2005)
7.	Franzosi, Maria Grazia: 4 articles (09/2007 - 04/2002)
8.	Nicolosi, Gian Luigi: 4 articles (09/2007 - 04/2002)
9.	Tognoni, Gianni: 4 articles (09/2007 - 04/2002)
10.	Maggioni, Aldo Pietro: 4 articles (09/2007 - 04/2002)

Related Diseases

1.	Neoplasms (Cancer) 01/01/2007 - "Among dietary factors, fish-derived n-3 polyunsaturated fatty acids (PUFAs) have gained particular interest, since epidemiological studies have shown a reduced incidence of this cancer in populations consuming high levels of fish. " 01/01/2005 - "There is now considerable evidence that polyunsaturated fatty acids (PUFA) are effective in vitro at limiting the growth of cancer cells while not affecting normal cells to the same extent. " 04/01/2008 - "Both epidemiologic and experimental findings suggest that omega-3 polyunsaturated fatty acids (omega-3 PUFAs), which are almost absent from typical Western diets, exert protective effects against cancer progression, although the precise mechanism of this suppression remains unknown. " 01/01/2007 - "Some studies have suggested that omega-3 polyunsaturated fatty acids (PUFAs) have an inhibitory effect on the growth of cancer cells and therefore have the potential to increase the efficacy of cancer chemotherapeutic drugs. " 02/01/2009 - "Studies show that n-3 polyunsaturated fatty acids (PUFA) inhibit proliferation and induce apoptosis in cancer cells. " Order ALL the reference details at left...
2.	Cardiovascular Diseases (Cardiovascular Disease) 08/01/2008 - "Omega 3 polyunsaturated fatty acids are promoted as beneficial in the prevention of metabolic and cardiovascular diseases. " 10/01/1997 - "Further identification of the mechanisms through which polyunsaturated fatty acids modulate early gene expression and regulate subsequent cellular responses, like cell growth, may help to define novel concepts in the management of cardiovascular diseases." 04/01/2009 - "Accumulating evidence demonstrates that dietary intake of n-3 polyunsaturated fatty acids (PUFAs) is associated with a reduced incidence of several cardiovascular diseases that involve endothelial dysfunction. " 12/01/2008 - "Preclinical and clinical studies have demonstrated that omega-3 polyunsaturated fatty acids (n-3 PUFAs) play a significant role in the prevention of cardiovascular disease. " 10/04/2008 - "BACKGROUND: Several epidemiological and experimental studies suggest that n-3 polyunsaturated fatty acids (PUFA) can exert favourable effects on atherothrombotic cardiovascular disease, including arrhythmias. " Order ALL the reference details at left...
3.	Atherosclerosis (Atheroma) 04/01/2009 - "Dietary polyunsaturated fatty acids are beneficial for the prevention of coronary artery atherosclerosis. " 01/01/2003 - "The aim of our studies was to find out if the trans-unsaturated fatty acids as well as acrylamide present in foods have the potential to provoke pro-inflammatory states in the body and enhance atherosclerosis risk. " 06/01/2000 - "Despite numerous studies, the precise role of dietary n-6 polyunsaturated fatty acids in the pathogenesis of atherosclerosis remains controversial. " 08/01/1998 - "These results indicate that the long-chain n-3 polyunsaturated fatty acids in fish oil may be hepatotoxic to the herbivorous rabbit, which may interfere with the outcome of atherosclerosis studies. " 12/01/2008 - "Dietary intake of long-chain n-3 polyunsaturated fatty acids (PUFA) reduces the risk for atherosclerosis. " Order ALL the reference details at left...
4.	Myocardial Infarction 09/01/2007 - "The GISSI-Prevenzione trial established the efficacy of n-3 polyunsaturated fatty acids (PUFAs) for reducing mortality in patients after recent myocardial infarction. " 09/01/2007 - "Efficacy of n-3 polyunsaturated fatty acids according to clinical characteristics of patients with recent myocardial infarction: insights from the GISSI-Prevenzione trial." 01/01/2001 - "Efficacy of n-3 polyunsaturated fatty acids after myocardial infarction: results of GISSI-Prevenzione trial. " 12/01/2006 - "Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione was the first large randomized trial to produce evidence that a pharmaceutical preparation of highly purified omega-3 polyunsaturated fatty acids (PUFAs), administered as an adjunct to other accepted interventions, had a favorable effect on hard clinical end-points in post-myocardial infarction patients. " 04/23/2002 - "BACKGROUND: Our purpose was to assess the time course of the benefit of n-3 polyunsaturated fatty acids (PUFAs) on mortality documented by the GISSI-Prevenzione trial in patients surviving a recent (<3 months) myocardial infarction. " Order ALL the reference details at left...
5.	Atrial Fibrillation 01/01/2008 - "Statins and polyunsaturated fatty acids for treatment of atrial fibrillation." 11/06/2007 - "BACKGROUND: There is epidemiological evidence that omega-3 polyunsaturated fatty acids (PUFAs) reduce the risk of atrial fibrillation (AF), but clinical data are conflicting. " 02/01/2007 - "BACKGROUND AND PURPOSE: Recent reports suggest that n-3 (omega-3) polyunsaturated fatty acids (PUFAs) may reduce atrial fibrillation (AF). " 01/01/2007 - "We present the hypothesis of non-hypoxic preconditioning based on the association of pretreatment with n-3 polyunsaturated fatty acids followed by ascorbate plus alpha-tocoferol supplementation diminishes the incidence of postoperative atrial fibrillation in patients subjected to cardiac surgery with extracorporeal circulation." 12/01/2005 - "Do n-3 polyunsaturated fatty acids prevent atrial fibrillation after coronary artery bypass grafting surgery?" Order ALL the reference details at left...

Related Drugs and Biologics

1.	Eicosapentaenoic Acid
2.	Omega-3 Fatty Acids (Omega 3 Fatty Acids)
3.	Fatty Acids (Saturated Fatty Acids)
4.	Fish Oils
5.	Monounsaturated Fatty Acids
6.	Arachidonic Acid (Vitamin F)
7.	Antioxidants
8.	Biological Markers (Surrogate Marker)
9.	Sodium
10.	Lipids

Related Therapies and Procedures

1.	Vegetarian Diet (Vegetarianism)
2.	Transplants (Transplant)
3.	Mediterranean Diet
4.	Renal Dialysis (Hemodialysis)
5.	Coronary Artery Bypass (Coronary Artery Bypass Surgery)

Best Treatments:
Research Summary Report
on Neoplasms

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 20112 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>